KLOW — Quad-Peptide Research Blend (80mg) | PeptiLab Canada

KLOW is an advanced four-peptide research formulation combining GHK-Cu, BPC-157, TB-500, and KPV into a single lyophilized compound. Building on the established Glow tri-peptide framework, KLOW adds KPV — a potent anti-inflammatory tripeptide — to create a comprehensive quad-peptide blend for multi-pathway laboratory research.

Each component targets a distinct biological mechanism, making KLOW a subject of significant interest in regenerative and cellular research protocols.

Supplied as sterile lyophilized powder for laboratory and in vitro research applications. Each batch is independently third-party tested and accompanied by a Certificate of Analysis (COA).

Formulation Breakdown:

• GHK-Cu (50mg) — Copper tripeptide studied for collagen synthesis, extracellular matrix remodeling, and cellular regeneration research
• BPC-157 (10mg) — Body Protection Compound researched for tissue repair, angiogenesis, and gut barrier studies
• TB-500 (10mg) — Thymosin Beta-4 analogue investigated for cell migration, tissue regeneration, and inflammatory response research
• KPV (10mg) — Anti-inflammatory tripeptide derived from α-MSH, studied for immune modulation, gut health, and antimicrobial activity

Specifications:

• Total peptide content: 80mg per vial
• Format: Lyophilized powder
• Purity: ≥99% (third-party verified)
• Storage: Refrigerate upon receipt. Reconstitute with bacteriostatic water.

Disclaimer: For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and laboratory professionals. PeptiLab products are not approved by Health Canada or the FDA for human use. Each batch is independently third-party tested for purity and identity; Certificates of Analysis are available on request.